Boğaziçi CT3

Social Media

Son Paylaşımlar
A New Collaboration to Strengthen the MedTech & BioTech Ecosystem
02.09.2026
A New Collaboration to Strengthen the MedTech & BioTech Ecosystem

We have entered into a new collaboration aimed at helping innovative ideas in health technologies evolve into market-ready products and sustainable ventures.

SCIENCE4ALL
29.08.2026
SCIENCE4ALL

SCIENCE4ALL is a national science festival and European Researchers’ Night initiative designed to bring science and society closer together.

Cell and Protein Technologies Platform
15.08.2026
Cell and Protein Technologies Platform

We look forward to welcoming you to this inspiring session at the intersection of computational medicine, drug discovery, and next-generation therapeutics.

SCIENCE4ALL KICK-OFF
07.08.2026
SCIENCE4ALL KICK-OFF

On Wednesday, 5 August 2026, we held the Kick-Off Meeting of our SCIENCE4ALL project at İstinye University.

How Reliable Is Your Osmium Result?
03.08.2026
How Reliable Is Your Osmium Result?

We continue to provide reliable and traceable analytical solutions in line with OECD GLP standards for research and drug development processes.

The Horizon Europe WIDERA Twinning 2026 Programme
30.07.2026
The Horizon Europe WIDERA Twinning 2026 Programme

Through international collaboration, researcher exchanges, training programmes, and cutting-edge AI research, ENLIGHT-AI will strengthen scientific excellence and contribute to the future of digital health.

San Diego for BIO International Convention 2026
23.06.2026
San Diego for BIO International Convention 2026

Meet Boğaziçi CT³ at BIO 2026 and let’s connect to build impactful biotech and medtech partnerships!

“From Molecule to Drug” Research Summer School
23.06.2026
“From Molecule to Drug” Research Summer School

Organized by Boğaziçi CT³, the “From Molecule to Drug” Research Summer School is an intensive five-day science programme specially designed for high school students who are interested in the natural sciences and passionate about research.

Boğaziçi CT³ & LifeSci Laboratory Animal Use Certificate Training Programme
19.06.2026
Boğaziçi CT³ & LifeSci Laboratory Animal Use Certificate Training Programme

As part of the programme, participants received both theoretical and hands-on training on ethical principles, national and international regulations, research methods, and experimental models used in studies involving laboratory animals.

TÜSEB 2026 Group B R&D Call
15.06.2026
TÜSEB 2026 Group B R&D Call

At the Boğaziçi University Center for Targeted Therapy Technologies – CT³, we are proud that three of our health technology projects have been awarded support under the TÜSEB Group B R&D Project Call.

Boğaziçi CT³ Open Events – 7
12.06.2026
Boğaziçi CT³ Open Events – 7

At our event titled “Beyond Clinical Practice: A Transcontinental Entrepreneur’s Journey in Personalized Drug Development,” we explored the translation of scientific research into innovative therapies, the dynamics of biotechnology entrepreneurship, and current developments in personalized medicine.

Boğaziçi CT³ Open Events – 6
11.06.2026
Boğaziçi CT³ Open Events – 6

At our event titled “From Targeted Therapies to Translational Biotechnology: Perspectives on Diagnostics, Engineering, and Entrepreneurship,” we had the pleasure of welcoming Prof. Dr. Özge Can.

TÜSEB Delegation Visits the CT³ Center
04.06.2026
TÜSEB Delegation Visits the CT³ Center

As the Boğaziçi University Center for Targeted Therapy Technologies (Boğaziçi CT³ / @bogazicict3), we were pleased to welcome a delegation from the Health Institutes of Türkiye (TÜSEB) to our center.

Boğaziçi CT³ Open Events – 7
03.06.2026
Boğaziçi CT³ Open Events – 7

For the seventh event in our Open Events Series at the Boğaziçi University Center for Targeted Therapy Technologies (CT³), we are pleased to welcome a distinguished physician, scientist, and biotechnology entrepreneur.

Boğaziçi CT³ Open Events – 6
02.06.2026
Boğaziçi CT³ Open Events – 6

For the sixth event in our Open Events Series at the Boğaziçi University Center for Targeted Therapy Technologies (CT³), we are delighted to welcome a distinguished academic and researcher.

OECD Good Laboratory Practice (GLP) Compliance Statement
24.05.2026
OECD Good Laboratory Practice (GLP) Compliance Statement

With our GLP- and GCP-compliant systems infrastructure and advanced analytical capabilities, we provide reliable, traceable services in line with high quality standards.

Laboratory Animal Use Certificate Training Programme
02.05.2026
Laboratory Animal Use Certificate Training Programme

Covering ethical principles, the 3Rs approach, experimental design, and hands-on laboratory techniques, this training programme is designed for researchers, students, and professionals who will work with laboratory animals.

Boğaziçi CT³ Joint Event – 8
28.04.2026
Boğaziçi CT³ Joint Event – 8

We look forward to welcoming you to this informative session at the intersection of biomaterials, engineering design, and technology-driven biomedical innovation.

Boğaziçi CT³ at Expomed Eurasia 2026!
28.04.2026
Boğaziçi CT³ at Expomed Eurasia 2026!

At Expomed Eurasia 2026, one of the key meeting points for innovation in health technologies, the Boğaziçi University Center for Targeted Therapy Technologies took part in the Innovation Area.

Boğaziçi CT³ at Expomed Eurasia 2026!
14.04.2026
Boğaziçi CT³ at Expomed Eurasia 2026!

At Expomed Eurasia 2026, one of the key meeting points for innovation in health technologies, the Boğaziçi University Center for Targeted Therapy Technologies took part in the Innovation Area.

Boğaziçi CT³ Joint Event – 7
14.04.2026
Boğaziçi CT³ Joint Event – 7

In the seventh joint seminar organized with the Boğaziçi University Biomedical Engineering Institute (BME), we will explore how medicine—particularly mental health—is evolving at the intersection of human experience, social context, and technological systems.

Phase 1 Study of Our Cancer Drug Completed!
09.04.2026
Phase 1 Study of Our Cancer Drug Completed!

The Phase 1 study of the cancer drug developed by Prof. Dr. Rana Sanyal of the Boğaziçi University Department of Chemistry has been completed.

The DIGI4AGE EDIH Project
08.04.2026
The DIGI4AGE EDIH Project

We believe that such engagements play a critical role in fostering meaningful connections and translating innovation into real-world impact. We look forward to future collaboration opportunities.

Boğaziçi CT³ Joint Event – 6
07.04.2026
Boğaziçi CT³ Joint Event – 6

We believe that such engagements play a critical role in fostering meaningful connections and translating innovation into real-world impact. We look forward to future collaboration opportunities.

Boğaziçi CT³ Joint Event – 5
24.03.2026
Boğaziçi CT³ Joint Event – 5

We look forward to welcoming you to this informative session at the intersection of engineering tools, biomedical research, and technology-driven innovation.

Boğaziçi CT³ Joint Event – 4
12.03.2026
Boğaziçi CT³ Joint Event – 4

We look forward to welcoming you to this inspiring session at the intersection of digital health, entrepreneurship, and globally scalable health technology innovation.

Boğaziçi CT³ Joint Event – 3
06.03.2026
Boğaziçi CT³ Joint Event – 3

We look forward to welcoming you to this inspiring session at the intersection of nanomedicine, photonic technologies, and next-generation cancer therapeutics.

Boğaziçi CT³ Joint Event – 2
26.02.2026
Boğaziçi CT³ Joint Event – 2

We look forward to welcoming you to this inspiring session at the intersection of biotechnology, ethical innovation, and sustainable industrial transformation.

Boğaziçi CT³ Open Events – 5
12.02.2026
Boğaziçi CT³ Open Events – 5

As part of our Strategic Partnerships and Business Development Seminar Series, this session takes us on a real-world deep-tech entrepreneurship journey spanning from the laboratory to artificial intelligence models.

Mavi: Aktif post Gri: Post yok